Development and applications of a real-time quantitative RT-PCR method (QRT-PCR) for BRCA1 mRNA

Clinical Biochemistry

Volumn 38, Issue 1, 2005, Pages 50-57

  Kroupis, Christos ^a   Stathopoulou, Aliki ^a   Zygalaki, Eleni ^a   Ferekidou, Lisa ^b   Talieri, Maroulio ^b   Lianidou, Evi S ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Antineoplastic agents; BRCA1; Gamma irradiation; Real time QRT PCR

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; DOXORUBICIN; ETOPOSIDE; FLUORESCEIN; FLUOROURACIL; MESSENGER RNA; PACLITAXEL;

ACCURACY; AMPLICON; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DNA PROBE; DRUG EFFECT; GAMMA IRRADIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PURIFICATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; BRCA1 PROTEIN; BREAST NEOPLASMS; CARCINOMA; FEMALE; GAMMA RAYS; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 10644254600     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.09.012     Document Type: Article

References (35)

1. Y. Miki, J. Swensen, D. Shattuck-Eidens, P.A. Futreal, K. Harshman, and S. Tavtigian A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 1994 66 71
2. M.C. King, J.H. Marks, and J.B. Mandell Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 2003 643 646
3. A. Ladopoulou, C. Kroupis, I. Konstantopoulou, L. Ioannidou-Mouzaka, A.C. Schofield, and A. Pantazidis Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed Cancer Lett. 185 2002 61 70
4. A. Tutt, and A. Ashworth The relationship between the roles of BRCA genes in DNA repair and cancer predisposition Trends Mol. Med. 8 2002 571 576
5. L.T. Seery, J.M. Knowlden, J.M. Gee, J.F. Robertson, F.S. Kenny, and I.Q. Ellis BRCA1 expression levels predict distant metastasis of sporadic breast cancers Int. J. Cancer 84 1999 258 262
6. C.T. Wittwer, K.M. Ririe, R.V. Andrew, D.A. David, R.A. Gundry, and U.J. Balis The LightCycler: a microvolume multisample fluorimeter with rapid temperature control BioTechniques 22 1997 176 181
7. P.S. Bernard, and C.T. Wittwer Real-time PCR technology for cancer diagnostics Clin. Chem. 48 2002 1178 1185
8. C. Egawa, Y. Miyoshi, Y. Takamura, T. Taguchi, Y. Tamaki, and S. Noguchi Decreased expression of BRCA2 mRNA predicts favorable response to docetaxel in breast cancer Int. J. Cancer 95 2001 255 259
9. C. Egawa, K. Motomura, Y. Miyoshi, Y. Takamura, T. Taguchi, and Y. Tamaki Increased expression of BRCA1 mRNA predicts favorable response to anthracycline-containing chemotherapy in breast cancers Breast Cancer Res. Treat. 78 2003 45 50
10. S. Lafarge, V. Sylvain, M. Ferrara, and Y.J. Bignon Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway Oncogene 20 2001 6597 6606
11. J. Su, and K. Ciftci Changes in BRCA1 and BRCA2 expression produced by chemotherapeutic agents in human breast cancer cells Int. J. Biochem. Cell Biol. 34 2002 950 957
12. R. Yuan, S. Fan, and J.A. Wang Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells Prostate 40 1999 37 49
13. T. Rattenborg, I. Gjermandsen, and E.C. Bonefeld-Jorgensen Inhibition of E2-induced expression of BRCA1 by persistent organochlorines Breast Cancer Res. 4 2002 R12 (Online)
14. S. Swami, A.V. Krishnan, and D. Feldman 1alpha, 25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells Clin. Cancer Res. 6 2000 3371 3379
15. J.T. Holt, M.E. Thompson, and C. Szabo Growth retardation and tumour inhibition by BRCA1 Nat. Genet. 12 1996 298 302
16. T. Spiropoulou, L. Ferekidou, and K. Angelopoulou Effect of antineoplastic agents on the expression of human telomerase reverse transcriptase beta plus transcript in MCF-7 cells Clin. Biochem. 37 2004 299 304
17. H. Ozcelik, M.D. To, J. Couture, S.B. Bull, and I.L. Andrulis Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers Int. J. Cancer 77 1998 1 6
18. J. Sambrook E.F. Fritsch T. Maniatis Molecular Cloning: A Laboratory Manual Second ed. 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
19. C.A. Wilson, M.N. Payton, and G.S. Elliott Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b Oncogene 14 1997 1 16
20. C.F. Xu, J.A. Chambers, H. Nicolai, M.A. Brown, Y. Hujeirat, and S. Mohammed Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families Genes Chromosomes Cancer 18 1997 102 110
21. A. Stathopoulou, A. Gizi, M. Perraki, S. Apostolaki, N. Malamos, and D. Mavroudis Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system Clin. Cancer Res. 9 2003 5145 5151
22. M. Mognato, P. Ferraro, and S. Canova Analysis of mutational effects at the HPRT locus in human G(0) phase lymphocytes irradiated in vitro with gamma rays Mutat. Res. 474 2001 147 158
23. K. Suzuki, and T.K. Hei Mutation induction in gamma-irradiated primary human bronchial epithelial cells and molecular analysis of the HPRT mutants Mutat. Res. 349 1996 33 41
24. C. Tricarico, P. Pinzani, S. Bianchi, M. Paglierani, V. Distante, and M. Pazzagli Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies Anal. Biochem. 309 2002 293 300
25. S. Gelmini, C. Tricarico, and G. Vona Real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the TaqMan detection system Clin. Chem. Lab. Med. 39 2001 385 391
26. B. Straub, M. Muller, and H. Krause Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using "Light-Cycler"-based quantitative real-time polymerase chain reaction Urology 58 2001 815 820
27. K. Wunderlich, C. Zimmerman, and H. Gutmann Vasospastic persons exhibit differential expression of ABC-transport proteins Mol. Vision 9 2003 756 761
28. S. Fan, N.F. Twu, and J.A. Wang Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation Int. J. Cancer 77 1998 600 609
29. J.L. Andres, S. Fan, and G.J. Turkel Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents Oncogene 16 1998 2229 2241
30. S. Lafarge, and M.H. Montane Characterization of Arabidopsis thaliana ortholog of the human breast cancer susceptibility gene 1: AtBRCA1, strongly induced by gamma rays Nucleic Acids Res. 31 2003 1148 1155
31. B. Aunoble, D. Bernard-Gallon, and Y.J. Bignon Regulation of BRCA1 and BRCA2 transcript in response to cisplatin, adriamycin, taxol and ionising radiation is correlated to p53 functional status in ovarian cancer cell lines Oncol. Rep. 8 2001 663 668
32. K. Trenz, J. Landgraf, and G. Speit Mutagen sensitivity of human lymphoblastoid cells with a BRCA1 mutation Breast Cancer Res. Treat. 78 2003 69 79
33. K. Trenz, A. Rothfuss, P. Schutz, and G. Speit Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutation Mutat. Res. 500 2002 89 96
34. M. Esteller, J.M. Silva, and G. Dominguez Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors J. Natl. Cancer Inst. 92 2000 564 569
35. J.C. Rice, K.S. Massey-Brown, and B.W. Futscher Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells Oncogene 17 1998 1807 1812